Uzair Ahmad et al. 2023. EFFICACY AND SAFETY OF VILDAGLIPTIN AS ADD-ON THERAPY TO PIOGLITAZONE IN PATIENTS WITH TYPE II DIABETES MELLITUS. Journal of Population Therapeutics and Clinical Pharmacology. 30, 18 (Nov. 2023), 2179–2184. DOI:https://doi.org/10.53555/jptcp.v30i18.3425.